An AV fistula is used over other alternatives, such as catheters or artificial grafts, since it uses the patient's veins, lowering the risk of infection, clotting, and other complications.

There is a considerable clinical need for alternatives to the autologous vein and artery tissues used for vascular reconstructive surgeries such as CABG, lower limb bypass, arteriovenous shunts ...

either an arteriovenous graft of synthetic material or a transposed brachial basilic vein fistula. The DOQI guidelines acknowledge the problems with basilic vein transposition (BVT) as two ...

Merit Medical Systems, Inc. MMSI, on Monday, announced the enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus ...

high-flux HD. Optimal vascular access through an arteriovenous fistula may help achieve high convection volume more effectively than a central venous catheter or graft. There are similar risks for ...

Humacyte’s initial product candidates, a portfolio of acellular tissue engineered vessels (ATEVs), are currently in ...

The ATEV is also being evaluated in clinical trials in arteriovenous (AV) access for hemodialysis and peripheral artery disease, and preclinical development is underway in coronary artery bypass ...

arteriovenous (AV) access for hemodialysis, and peripheral artery disease. A Biologics License Application for the ATEV in the vascular trauma indication was approved by the FDA in December 2024.

Vascular graft rupture has occurred in patients treated ... including vascular trauma repair, arteriovenous (AV) access for hemodialysis, and peripheral artery disease. A Biologics License ...

Perivascular adipose tissue (PVAT) plays a crucial, yet underexplored, role in vein remodeling, which occurs after bypass surgery using a venous graft or creation of arteriovenous fistulae for ...